Rapid progress in T-cell–based cancer research is reshaping the landscape of modern oncology, offering renewed hope for patients with hard-to-treat malignancies. Scientists and clinicians are increasingly harnessing the immune system’s natural ability to identify and destroy cancer cells, moving beyond conventional chemotherapy and radiation. Breakthroughs in immunotherapy—particularly T-cell–focused approaches—are delivering more targeted treatments with the potential for longer-lasting remission.